Portfolio Performance (Crispr, Microvision, Hive Blockchain)

Here are some metrics and notes on the portfolio. The portfolio reflects the performance of the resources available executing the mission of KDK Fund.  

Security/Project	Type of Investment	Date of Investment Purchase	Cost of Investment	Current Value of Investment	Return %
Crispr Therapeutics	Stock	3/23/2020	$38.78	54.01	39.27%
Microvision	Stock	3/23/2020	$0.18	0.25	38.89%
Hive Blockchain	Stock	4/16/2020	$0.16	0.23	43.75%

Week's Notes

- Crispr Therapeutics - will likely be announcing earnings on April 27th.

- Hive Blockchain - Bitcoin halving in May 2020 (definition of halvening through Gemini Capital found here).

- Microvision - Company shareholder meeting on May 19th, 2020 (link here).

- The fund will continue to look for opportunities to improve the fund. The next likely entry into the portfolio will be energy related.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.